This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

24/7 Access
Digital & In-Person

Fa Liu, PhD
Director of Discovery Chemistry at Novo Nordisk Research Center Seattle


Dr. Liu is the Director of Discovery Chemistry at Novo Nordisk Research Center, where he is leading the chemistry department to drive the peptide and protein therapeutics discovery targeting obesity, diabetes and other metabolic diseases. Prior to joining Novo, he was the Director of Chemistry at Calibrium Biotech where he played instrumental roles in building up the company portfolio (2014-2015). Dr. Liu started his industrial career at Eli Lilly (2009-2014) where he led the peptide lead optimization efforts across various disease areas and the establishment of novel insulin chemistries. He has advanced significant number of discovery programs including two into clinical trials and many into preclinical development. Dr. Liu has published more than 60 scientific articles and patents. Dr. Liu received his Ph.D. from the Shanghai Institute of Organic Chemistry in 2004 followed by a five year stay at the National Cancer Institute as a postdoctoral fellow (2004-2007) and a staff scientist (2007-2009).